Striking the Right Balance: The Role of n-3/n-6 Fatty Acid Ratio in Health and Strategies for Dietary Improvement.

Year : 2026 | Volume : 03 | Issue : 01 | Page : 1 9
    By

    Poonam Bakhetia,

  1. Assistant Professor,, Department of Food and Nutrition, College of Community Science, PAU,, Ludhiana, Punjab, India

Abstract

The dietary balance between omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acids (PUFAs) is crucial in modulating inflammation and promoting optimal physiological function. Modern diets, particularly in industrialized countries, are skewed heavily in favor of n-6 fatty acids, often reaching ratios as high as 1:20 or more, compared to the ideal range of 1:1 to 1:4. This imbalance is associated with the pathogenesis of numerous chronic diseases, including cardiovascular conditions, obesity, diabetes, neurodegenerative disorders, and certain cancers. This review integrates evidence from approximately 45 original research studies to discuss the biological relevance of the n-3/n-6 ratio, its implications for health, and feasible dietary strategies for restoring balance. It also explores historical and cultural dietary patterns, biochemical pathways, and emerging public health interventions. The restoration of a healthy n-3/n-6 ratio is not only a nutritional priority but a public health imperative.This review integrates evidence from approximately 45 original research studies to discuss the biological relevance of the n-3/n-6 ratio, its implications for health, and feasible dietary strategies for restoring balance. It also explores historical and cultural dietary patterns, biochemical pathways, and emerging public health interventions. The restoration of a healthy n-3/n-6 ratio is not only a nutritional priority but a public health imperative.

 

Keywords: Keywords: Omega-3 fatty acids (n-3 PUFAs), omega-6 fatty acids (n-6 PUFAs), n-3/n-6 ratio, polyunsaturated fatty acids, inflammation modulation

[This article belongs to International Journal of Nutritions ]

How to cite this article:
Poonam Bakhetia. Striking the Right Balance: The Role of n-3/n-6 Fatty Acid Ratio in Health and Strategies for Dietary Improvement.. International Journal of Nutritions. 2026; 03(01):1-9.
How to cite this URL:
Poonam Bakhetia. Striking the Right Balance: The Role of n-3/n-6 Fatty Acid Ratio in Health and Strategies for Dietary Improvement.. International Journal of Nutritions. 2026; 03(01):1-9. Available from: https://journals.stmjournals.com/ijn/article=2026/view=239106


References

  1. Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: Health benefits throughout life. Adv Nutr. 2012;3(1):1–7.
  2. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365–379.
  3. Yashodhara BM, Umakanth S, Pappachan JM, Bhat SK, Kamath R, Choo BH. Omega-3 fatty acids: A comprehensive review of their role in health and disease. Postgrad Med J. 2009;85(1000):84–90. doi: 1136/pgmj.2008.073338. PMID: 19329703.
  4. Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. 2009:668–679.
  5. Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001;36(9):1007–1024.
  6. Calder PC. Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochem Soc Trans. 2017;45(5):1105–1115. doi: 1042/BST20160474. PMID: 28900017.
  7. Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. Health implications of high dietary omega-6 polyunsaturated fatty acids. J Nutr Metab. 2012;2012:539426. doi: 1155/2012/539426. PMID: 22570770.
  8. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747–2757.
  9. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: Effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047–2067.
  10. Rizos EC, Ntzani EE, Bika E. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. Database of Abstracts of Reviews of Effects (DARE). 2012.
  11. Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr. 2000;71(1 Suppl):171S–175S. doi: 1093/ajcn/71.1.171S. PMID: 10617967.
  12. DiNicolantonio JJ, O’Keefe JH. Omega-6 vegetable oils as a driver of coronary heart disease: The oxidized linoleic acid hypothesis. Open Heart. 2018;5(2):e000898. doi: 1136/openhrt-2018-000898. PMID: 30364556.
  13. Lemaitre RN, King IB, Mozaffarian D, Sotoodehnia N, Rea TD, Kuller LH, et al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: The cardiovascular health study. Circulation. 2006;114(3):209–215. doi: 1161/CIRCULATIONAHA.106.620336. PMID: 16818809.
  14. Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr. 2006;83(6 Suppl):1526S–1535S. doi: 1093/ajcn/83.6.1526S. PMID: 16841863.
  15. Pan A, Chen M, Chowdhury R, Wu JH, Sun Q, Campos H, et al. α-Linolenic acid and risk of cardiovascular disease: A systematic review and meta-analysis. Am J Clin Nutr. 2012;96:1262–1273. doi: 3945/ajcn.112.044040.
  16. Simopoulos AP. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3):128. doi: 3390/nu8030128. PMID: 26950145.
  17. Lin S, Cienfuegos S, Ezpeleta M, Pavlou V, Corapi S, Runchey MC, et al. Time-restricted eating versus daily calorie restriction: Effects on inflammatory markers over 12 months in adults with obesity. Nutrients. 2025;17(7):1130. doi: 3390/nu17071130. PMID: 40218888.
  18. Kalupahana NS, Claycombe KJ, Moustaid-Moussa N. (n-3) fatty acids alleviate adipose tissue inflammation and insulin resistance: Mechanistic insights. Adv Nutr. 2011;2(4):304–316. doi: 3945/an.111.000505. PMID: 22332072.
  19. Talon LC, Erick PO, Moreto F, Portero-McLellan KC, Burini RC. Omega-3 fatty acids supplementation decreases metabolic syndrome prevalence after lifestyle modification program. J Funct Foods. 2015;19:922–928.
  20. Bogl LH, Kaprio J, Pietiläinen KH. Dietary n-6 to n-3 fatty acid ratio is related to liver fat content independent of genetic effects: Evidence from the monozygotic co-twin control design. Clin Nutr. 2020;39(7):2311–2314. doi: 1016/j.clnu.2019.10.011. PMID: 31668723.
  21. Liu J, Li X, Hou J, Sun J, Guo N, Wang Z. Dietary intake of n-3 and n-6 polyunsaturated fatty acids and risk of cancer: Meta-analysis of data from 32 studies. Nutr Cancer. 2021;73(6):901–913. doi: 1080/01635581.2020.1779321. PMID: 32530319.
  22. Gogus U, Smith C. n-3 omega fatty acids: A review of current knowledge. Int J Food Sci Technol. 2010;45(3):417–436.
  23. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(6 Suppl):1505S–1519S. doi: 1093/ajcn/83.6.1505S. PMID: 16841861.
  24. Gu Z, Shan K, Chen H, Chen YQ. n-3 polyunsaturated fatty acids and their role in cancer chemoprevention. Curr Pharmacol Rep. 2015;1(5):283–294. doi: 1007/s40495-015-0043-9. PMID: 26457243.
  25. Zhou K, Zhang Q, Yuan Z, Yan Y, Zhao Q, Wang J. Plasma fatty acids and attention deficit hyperactivity disorder: A Mendelian randomization investigation. Front Psychiatry. 2024;15:1368942. doi: 3389/fpsyt.2024.1368942. PMID: 38764473.
  26. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, et al. Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67(12):1954–1967. doi: 4088/jcp.v67n1217. PMID: 17194275.
  27. Guesnet P, Alessandri JM. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) – Implications for dietary recommendations. Biochimie. 2011;93(1):7–12. doi: 1016/j.biochi.2010.05.005. PMID: 20478353.
  28. Chang JP, Su KP, Mondelli V, Pariante CM. Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: A systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology. 2018;43(3):534–545. doi: 1038/npp.2017.160. PMID: 28741625.
  29. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 2003;111(1):e39–44. doi: 1542/peds.111.1.e39. PMID: 12509593.
  30. Innis SM. Dietary omega-3 fatty acids and the developing brain. Brain Res. 2008;1237:35–43. doi: 1016/j.brainres.2008.08.078. PMID: 18789910.
  31. Oken E, Wright RO, Kleinman KP, Bellinger D, Amarasiriwardena CJ, Hu H, et al. Maternal fish consumption, hair mercury, and infant cognition in a U.S. cohort. Environ Health Perspect. 2005;113(10):1376–1380. doi: 1289/ehp.8041. PMID: 16203250.
  32. Ramakrishnan U, Grant F, Goldenberg T, Zongrone A, Martorell R. Effect of women’s nutrition before and during early pregnancy on maternal and infant outcomes: A systematic review. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:285–301. doi: 1111/j.1365-3016.2012.01281.x. PMID: 22742616.
  33. Huang TL. Omega-3 fatty acids, cognitive decline, and Alzheimer’s disease: A critical review and evaluation of the literature. J Alzheimers Dis. 2010;21(3):673–690.
  34. Serhan CN, Levy BD. Resolvins in inflammation: Emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018;128(7):2657–2669.
  35. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: The anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev. 2010;68(5):280–289. doi: 1111/j.1753-4887.2010.00287.x. PMID: 20500789.
  36. Marton LT, Goulart RA, Carvalho ACA, Barbalho SM. Omega fatty acids and inflammatory bowel diseases: An overview. Int J Mol Sci. 2019;20(19):4851. doi: 3390/ijms20194851. PMID: 31574900.
  37. Van Vliet T, Katan MB. Lower ratio of n-3 to n-6 fatty acids in cultured than in wild fish. Am J Clin Nutr. 1990;51(1):1–2. doi: 1093/ajcn/51.1.1. PMID: 2296923.
  38. Saidaiah P, Banu Z, Khan AA, Geetha A, Somraj B. A comprehensive review of omega-3 fatty acids: Sources, industrial applications, and health benefits. Ann Phytomed. 2024;13(1):209–225.
  39. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011;93(5):950–962. doi: 3945/ajcn.110.006643. PMID: 21367944.
  40. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008;233(6):674–688.
  41. Meyer BJ. Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health? 2011:275–280.
  42. Deckelbaum RJ, Torrejon C. The omega-3 fatty acid nutritional landscape: Health benefits and sources. J Nutr. 2012;142(3):587S–591S. doi: 3945/jn.111.148080.
  43. Goyens PL, Spiker ME, Zock PL, Katan MB, Mensink RP. Conversion of α-linolenic acid in humans is influenced by the absolute amounts of α-linolenic acid and linoleic acid in the diet and not by the ratio. Am J Clin Nutr. 2006;84:44–35.
  44. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83(6 Suppl):1467S–1476S. doi: 1093/ajcn/83.6.1467S. PMID: 16841856.
  45. Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids. 2009;80(2-3):85–91. doi: 1016/j.plefa.2009.01.004. PMID: 19269799.
  46. Lien EL. Toxicology and safety of DHA. Prostaglandins Leukot Essent Fatty Acids. 2009;81:125–132. doi: 1016/j.plefa.2009.05.004.
Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 10/05/2025
Accepted 01/08/2025
Published 24/03/2026
Publication Time 318 Days
35

Login


My IP

PlumX Metrics